• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

ProShares Ultra Nasdaq Biotechnology

+ Add to Watchlist

BIB:US

101.7500 USD 3.4300 3.49%

As of 14:12:12 ET on 09/16/2014.

Snapshot for ProShares Ultra Nasdaq Biotechnology (BIB)

Open: 96.7200 High - Low: 101.7500 - 96.7200 Primary Exchange: NASDAQ GM
Volume: 169,019 52-Week Range: 54.0400 - 109.7400 Beta vs NBI: 1.6844

ETF Chart for BIB

No chart data available.
  • BIB:US 101.7500
  • 1D
  • 1M
  • 1Y
98.3200
Interactive BIB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BIB

ProShares Ultra Nasdaq Biotechnology is an an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to twice (200%) the return of the Nasdaq Biotechnology Index.

Inception Date: 2010-04-08 Telephone: 1-240-497-6400
Managers: HOWARD S RUBIN
Web Site: www.proshares.com

Fundamentals for BIB

NAV (on 2014-09-15) 98.4000
Assets (M) (on 2014-09-15) 329.6469
Shares out (M) 3.35
Market Cap (M) 330.31
% Premium -0.08
Average 52-Week % Premium 0.0131
Fund Leveraged Y
Fund Leverage Percent 200.0000 %

Dividends for BIB

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) -%

Performance for BIB

1-Month +1.57% 1-Year +52.96%
3-Month +14.14% 3-Year +85.07%
Year To Date +30.67% 5-Year -
Expense Ratio 0.95

Top Fund Holdings for BIB

Filing Date: 12/31/2013
Name Position Value % of Total
Celgene Corp 164,568 13,902,705 6.154%
Gilead Sciences Inc 177,932 13,371,590 5.919%
Amgen Inc 116,682 13,320,417 5.896%
Biogen Idec Inc 45,747 12,797,723 5.665%
Regeneron Pharmaceuticals Inc 40,565 11,165,111 4.942%
Vertex Pharmaceuticals Inc 95,874 7,123,438 3.153%
Alexion Pharmaceuticals Inc 53,459 7,113,255 3.149%
Mylan Inc/PA 150,816 6,545,414 2.897%
Illumina Inc 55,371 6,125,140 2.711%
BioMarin Pharmaceutical Inc 62,299 4,377,751 1.938%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil